Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13

The Journal of Infectious Diseases
T van der PollS F Lowry

Abstract

Plasma concentrations of soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13 were measured in 42 patients with clinically defined sepsis during a 3-day follow-up and in 7 healthy humans after intravenous injection of endotoxin (2 ng/kg). Levels of soluble IL-1 receptor type II were persistently elevated in patients with sepsis than in healthy controls and higher in nonsurviving patients (n = 22) than in surviving patients (n = 20) at all time points. IL-10 was found in the circulation of 81% of patients with sepsis, while it was not detectable in normal plasma. During follow-up, IL-10 remained invariably high only in nonsurviving patients, while it significantly decreased in survivors. Endotoxin induced IL-10, while soluble IL-1 receptor type II remained unchanged. IL-13 remained undetectable in the vast majority of patients and was not induced by endotoxin. Enhanced IL-13 production does not seem to be part of an inducible host defense mechanism during sepsis.

Citations

Mar 10, 2012·Journal of Materials Science. Materials in Medicine·Uwe WalschusMichael Schlosser
Oct 30, 1999·The Annals of Thoracic Surgery·J LoCiceroL Zhang
Jun 16, 2001·Clinical Biochemistry·J TaïebT Poynard
May 22, 1998·General Pharmacology·B Klosterhalfen, R S Bhardwaj
May 26, 1999·Infectious Disease Clinics of North America·J Carlet
Apr 4, 2000·European Journal of Internal Medicine·J W FijenJ E Tulleken
May 30, 2001·Trends in Immunology·A MantovaniP Allavena
Apr 11, 2002·Acta Anaesthesiologica Scandinavica·P ToftF Dagnaes-Hansen
Jan 20, 2006·Acta Paediatrica·Alfredo Blanco-QuirósEduardo Arranz Sanz
Sep 16, 2011·The Journal of Infectious Diseases·Chong LiuDing-Feng Su
Jan 11, 2000·Critical Care Medicine·M O SimovicJ A Windsor
May 15, 2002·Critical Care Medicine·Beatriz M Tavares-MurtaFernando Q Cunha
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·A A KhanJ S Remington
Feb 17, 2001·Infection and Immunity·R C ReddyT J Standiford
Jun 18, 2002·Infection and Immunity·Claudia Farias BenjamimFernando Queiroz Cunha
Jul 16, 2002·Infection and Immunity·Samir Q LatifiAlan D Levine
Mar 13, 2001·Annual Review of Immunology·K W MooreA O'Garra
Dec 24, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Yufen WeiWeidong Zhang
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·N P JuffermansT van der Poll
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Thierry Fumeaux, Jérôme Pugin
Dec 7, 2007·AIDS Research and Therapy·Esaki Muthu ShankarNagalingeswaran Kumarasamy
Nov 26, 2013·Legal Medicine·Hidemichi KuboMamoru Ogata
Jan 9, 2014·Expert Opinion on Biological Therapy·Verbena Y KosovrastiMansoor M Amiji
Apr 30, 2003·Cytometry. Part B, Clinical Cytometry·Markus RothenburgerRasjid Soeparwata
May 1, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Chun-Kuang ShihSing-Chung Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved